openPR Logo
Press release

Portal Hypertension Market - Positive Long-Term Growth Outlook 2017 - 2025

09-04-2017 03:19 PM CET | Health & Medicine

Press release from: TMR Research

Portal Hypertension Market - Positive Long-Term Growth Outlook 2017 - 2025

Global Portal Hypertension Market: Snapshot

At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. The generic drugs hold a sway over the market and the scope of treatment under them include beta blockers, vasopressin and its analogues, and somatostatin and its analogues. In the near future, the portal hypertension market is primed to grow at a healthy clip due to the spike in liver cirrhosis, which may cause portal hypertension and other hepatic disorders.

Portal hypertension results in increase of blood pressure within the portal venous system. It may cause veins in stomach, esophagus, umbilical area, or rectum to swell. In extreme cases, these swollen vein can rupture and bleed, thereby causing life-threatening complications.

Some of the noteworthy candidates under phase III of clinical trials are Udenafil (DA-8519), Sapropterin (tetrahydrobiopterin), and Octreolin (octreotide). When approved and launched, these drugs would have the potential to rake in substantial revenue in the market.

Request Sample Copy of the Report @
www.tmrresearch.com/sample/sample?flag=B&rep_id=56

As far as diagnosis is concerned, Duplex Doppler ultrasonography has been seeing robust demand on being the current available imaging technique applied for diagnosing portal hypertension. Besides this, methods such as angioplasty, computed tomography (CT) scanning, bleeding scan, and magnetic resonance imaging (MRI) are also considered aviable methods for precise diagnosis.

Noteworthy names operating in the global portal hypertension market are Ono Pharmaceutical Co., Ltd., Dong-A Socio Holdings Co Ltd., Novartis AG, United Therapeutics Corporation, Genextra S.p.a., Aptalis Pharma Inc., Gilead Sciences, Inc., Debiovision, Inc., Chiasma, Inc., Govind Ballabh Pant Hospital, and Dr. Falk Pharma GmbH.

Global Portal Hypertension Market: Overview

Portal hypertension is a clinical condition in which blood pressure within the portal venous system increases. The condition may lead to the development of swollen veins within stomach, esophagus, umbilical area, or rectum. In severe cases, these swollen vein can rupture and bleed, thereby leading to potentially life-threatening complications. As per reports, liver cirrhosis is the most common cause of portal hypertension. Hence a rising incidence of liver cirrhosis is often related to the increasing demand for effective treatment for portal hypertension.

In this report, Transparency Market Research (TMR) not only evaluates opportunities prevalent for the available treatment and diagnosis techniques for portal hypertension but also presents a detailed assessment of therapeutic pipeline. The potential market trajectory post approval of novel therapeutics is determined based on exhaustive information obtained from proven industrial sources. The report thus compiles data aimed at providing a comprehensive overview of the global portal hypertension market to the readers.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=56

Global Portal Hypertension Market: Available Treatment Options

Duplex Doppler ultrasonography has been witnessing significantly high demand on being the current available imaging technique applied for diagnosing portal hypertension. Besides this, methods such as a computed tomography (CT) scanning, bleeding scan, angioplasty, and magnetic resonance imaging (MRI) are also considered viable methods for precise diagnosis. As these constitute key segments in the global hypertension market, the report presents an in-depth analysis of the factors influencing the market’s trajectory across aforementioned segments.

The currently available treatment for portal hypertension includes medications comprising beta blockers such as Propranolol and Nadolol and endoscopic therapies such as sclerotherapy and banding. Vasoactive agents are also preferred in the treatment of portal hypertension due to its ability of reducing the in-variceal bleeding and ultimately helping to lower the blood pressure. In acute conditions vasoconstrictors such as octreotide and somastostatin are administered, which explains their high demand in the global portal hypertension market.

Global Portal Hypertension Market: Therapeutics and Pipeline Analysis

The global market for portal hypertension currently has a limited number of treatment options and there is absence of a specialized drugs approved to be administered for the treatment of portal hypertension. However, the generic drugs segment currently holds dominance in the market, the scope of treatment under which includes vasopressin and its analogues, beta blockers, and somatostatin and its analogues. This also demonstrates lucrative prospects for therapeutic research and development. As per TMR, the portal hypertension market is poised to exhibit exponential growth on account of the increasing incidence of liver cirrhosis, which may lead to portal hypertension and other hepatic disorders.

Request Discount of the Report @ www.tmrresearch.com/sample/sample?flag=D&rep_id=56

The pipeline analysis of the market consists of products currently under the phase III of clinical trials. Some of the most notable candidates are Sapropterin (tetrahydrobiopterin), Octreolin (octreotide), and Udenafil (DA-8519). Once approved, the launch of these drugs could generate high revenue for the market.

Global Portal Hypertension Market: Vendor Landscape

To study the competition prevailing in the global portal hypertension market, the report profiles a few of the companies operating therein. It conducts SWOT analysis to evaluate the strengths and weaknesses of the companies profiled and identify threats and opportunities that these enterprises could face over the course of the forecast period. Some of the prominent players in the global portal hypertension market are Ono Pharmaceutical Co., Ltd., United Therapeutics Corporation, Chiasma, Inc., Genextra S.p.a., Aptalis Pharma Inc., Gilead Sciences, Inc., Debiovision, Inc., Dong-A Socio Holdings Co Ltd., Govind Ballabh Pant Hospital, Dr. Falk Pharma GmbH, and Novartis AG.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Portal Hypertension Market - Positive Long-Term Growth Outlook 2017 - 2025 here

News-ID: 697469 • Views: 187

More Releases from TMR Research

Healthcare Regulatory Affairs Outsourcing Market - Overview On Upcoming Need 202 …
Global Healthcare Regulatory Affairs Outsourcing Market: Snapshot The healthcare regulatory affairs outsourcing market is experiencing significant growth owing to services to Clinical Research Organizations. The rising number of patent expirations along with growing costs of research and development activities are the primary factors influencing the growth of the global healthcare regulatory affairs outsourcing market. Healthcare and biopharmaceutical organizations are likely to team up with numerous outsourcing companies for getting their drugs
Physician Office Laboratory (POL) Market - Current Opportunities 2025 | Accriva …
Global Physician Office Laboratory (POL) Market: Snapshot The global Physician Office Laboratory (POL) Market has been expanding substantially over the last few years. Supported by the technological advancements, the market is likely to remain proliferating over the next few years. POL testing has its base in developed regions as emerging economies still rely on hospital infrastructure for the diagnosis of acute and chronic medical conditions. Developing regions, however, has been demonstrating
Urological Catheters Market - Insights On Scope 2025 | Bard Medical, Rochester M …
Global Urological Catheters Market: Snapshot Catheters are medical instruments that are commonly used when a patient is unable to empty his or her bladder. If urine is allowed to build up in the patient’s bladder for a long time, the rising pressure in the kidneys can lead to kidney failure. The elderly people and patients with severe illness or injuries might need to use catheters for longer periods of time than
Tinnitus Market - Comprehensive Survey On Demand 2025 | Auris Medical Holding AG …
Global Tinnitus Market: Snapshot The global tinnitus market exhibited impressive growth in the recent past as the number of people suffering from tinnitus has been increasingly continuously. Tinnitus is a physical condition that occurs within an ear when there is no external noise mainly considered as a hearing perception. In most of the cases tinnitus occurs due to fluctuation in cochlea’s nerve activity as the auditory inputs are reduced. There are

All 25863 Releases


More Releases for Portal Hypertension Pharma

Portal Hypertension Market - Qualitative Opportunities 2025 | Ono Pharmaceutical …
Global Portal Hypertension Market: Snapshot At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. The generic drugs hold a sway over the market and the scope of treatment under them include beta blockers, vasopressin and its analogues, and somatostatin and its analogues. In the near future, the portal hypertension market is primed to grow at a healthy clip due to the spike
Portal Hypertension Market competitive landscape 2017-2025 : Govind Ballabh Pant …
Global Portal Hypertension Market: Snapshot At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. The generic drugs hold a sway over the market and the scope of treatment under them include beta blockers, vasopressin and its analogues, and somatostatin and its analogues. In the near future, the portal hypertension market is primed to grow at a healthy clip due to the spike
Portal Hypertension Market Overview 2017 - 2025 : Chiasma, Inc., Govind Ballabh …
Global Portal Hypertension Market: Snapshot At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. The generic drugs hold a sway over the market and the scope of treatment under them include beta blockers, vasopressin and its analogues, and somatostatin and its analogues. In the near future, the portal hypertension market is primed to grow at a healthy clip due to the spike
Portal Hypertension Market global Industry Analysis 2017-2025 : Govind Ballabh P …
Global Portal Hypertension Market: Snapshot At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. The generic drugs hold a sway over the market and the scope of treatment under them include beta blockers, vasopressin and its analogues, and somatostatin and its analogues. In the near future, the portal hypertension market is primed to grow at a healthy clip due to the spike